Trademark: 90238399
Word
KRASLOQ
Status
Dead
Status Code
606
Status Date
Monday, February 6, 2023
Serial Number
90238399
Mark Type
4000
Filing Date
Tuesday, October 6, 2020
Published for Opposition
Tuesday, November 9, 2021
Abandoned Date
Monday, February 6, 2023

Trademark Owner History
Mirati Therapeutics, Inc. - Owner At Publication

Classifications
5 pharmaceutical products for use in oncology; pharmaceutical products for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of lung cancer; pharmaceutical preparations for the treatment of non-small cell lung carcinoma; pharmaceutical preparations for the treatment of colorectal carcinoma; pharmaceutical preparations for the treatment of pancreatic cancer; pharmaceuticals comprising small molecules; pharmaceuticals comprising small molecules for the treatment of cancer; pharmaceuticals comprising small molecules for the treatment of infectious diseases; pharmaceuticals comprising small molecules for the treatment of lung cancer; pharmaceuticals comprising small molecules for the treatment of non-small cell lung carcinoma; pharmaceuticals comprising small molecules for the treatment of colorectal carcinoma; pharmaceuticals comprising small molecules for the treatment of pancreatic cancer; pharmaceuticals comprising compounds; pharmaceuticals comprising compounds for the treatment of cancer; pharmaceuticals comprising inhibitors; pharmaceuticals comprising inhibitors for the treatment of cancer; pharmaceuticals for the treatment of solid tumors; pharmaceuticals for the treatment of advanced solid tumors
42 research and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology; research and development of pharmaceuticals; providing information in the field of scientific and medical research related to pharmaceuticals

Trademark Events
Feb 6, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Feb 6, 2023
Abandonment - No Use Statement Filed
Jul 2, 2022
Notice Of Approval Of Extension Request E-Mailed
Jun 30, 2022
Sou Extension 1 Granted
Jun 30, 2022
Sou Extension 1 Filed
Jun 30, 2022
Sou Teas Extension Received
Jan 4, 2022
Noa E-Mailed - Sou Required From Applicant
Nov 9, 2021
Official Gazette Publication Confirmation E-Mailed
Nov 9, 2021
Published For Opposition
Oct 20, 2021
Notification Of Notice Of Publication E-Mailed
Oct 1, 2021
Approved For Pub - Principal Register
Sep 10, 2021
Teas/Email Correspondence Entered
Sep 9, 2021
Correspondence Received In Law Office
Sep 9, 2021
Teas Response To Office Action Received
Jun 30, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Jun 30, 2021
Teas Change Of Correspondence Received
Jun 30, 2021
Teas Change Of Owner Address Received
Mar 10, 2021
Notification Of Non-Final Action E-Mailed
Mar 10, 2021
Non-Final Action E-Mailed
Mar 10, 2021
Non-Final Action Written
Mar 4, 2021
Assigned To Examiner
Nov 20, 2020
New Application Office Supplied Data Entered
Oct 9, 2020
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24